Search

everythinglearnresearchcommunity

for

Search:↓

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

A vitamin D receptor mutation causes rickets and affects immune responses.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Psychological stress and personal history are significant factors in hair loss.

Ginsenoside CK, found in Panax ginseng, can prevent hair loss by controlling certain growth pathways and promoting hair follicle development.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Zinc is important for skin health, and supplements can help treat various skin and hair disorders, but more research is needed for conditions like psoriasis and vitiligo.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Isotretinoin affects trace element levels and requires monitoring of liver and kidney functions.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Low androgen levels can still cause female pattern hair loss.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Certain hormone treatments can improve acne and related conditions in women.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.